Friday June 17th, 2016

Dr. Rafael Penadés has been awarded with a Brain and Behavior Research Foundation Grant

Dr. Rafael Penadés, psychologist from the Schizophrenia Unit at Hospital Clínic and researcher at the IDIBAPS team Biological bases of psychiatric disorders and nuclear psychiatry and CIBERSAM, has been awarded with a grant from the Brain and Behavior Research Foundation within its program NARSAD Independent Investigator Grants. This foundation is one the largest private foundations in the United States dedicated to the research promotion in brain diseases such as sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, depression and schizophrenia.

Read the rest of this entry »

Categories

Posted in:

Tuesday June 14th, 2016

Andreu Mas-Colell encourages researchers from IDIBAPS to apply for a grant from the European Research Council

Professor at the University Pompeu Fabra (UPF), Andreu Mas-Colell, encourages researchers from IDIBAPS to “apply for an European Research Council (ERC) grant given the high scientific level in this institution”. Professor Mas-Colell made these remarks during the inaugural conference of the celebrations of the 20th anniversary of IDIBAPS on Monday 30th May.

Read the rest of this entry »

Friday June 10th, 2016

Dr. Elías Campo, awarded with the 2016 Rey Jaime I prize in the Medical Research category

Dr. Elías Campo, Research Director at Hospital Clínic, head of the Human and experimental functional oncomorphology team at IDIBAPS and Chair at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB), has been awarded with the “Rey Jaime I” award in the “medical research” category. Last Tuesday the list of winners of the 2016 edition of the awards was announced in an official ceremony held at the Palace of the Generalitat Valenciana, with the presence of the board chairman, Ximo Puig; the president of the Valencian Foundation for Advanced Studies and Vice President of the Rey Jaime I” Awards Foundation, Vicente Boluda, and the Permanent Secretary of the “Rey Jaime I” Awards, Santiago Grisolía.

Read the rest of this entry »

Thursday June 9th, 2016

First molecular test that enables fine-tuned prognosis and prediction in advanced breast cancer

Published today in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s (VHIO) Translational Genomics Group, and now  Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute (IDIBAPS), and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat, has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer. Findings show that the genomic classification of tumors — the molecular subtyping of primary tumors, can predict the evolution of patients from the onset of metastasis and that this cancer intrinsic classification can better guide treatment decisions in the first-line metastatic setting.  Read the rest of this entry »

Categories

Posted in:

Tuesday June 7th, 2016

Mediterranean diet high in healthy fat does not lead to weight gain

A Mediterranean diet which is rich in vegetal fats (extra virgin olive oils, dried fruit and nuts, etc.) does not mean it comes with weight gain if compared to a low-fat diet, according to a study published in the medical journal The Lancet Diabetes & Endocrinology. This work suggests that lots of current guidelines on health giving advice on reducing fat and calories give a wrong idea of the effects of consuming Mediterranean diet fats, a diet with well known health benefits.

Read the rest of this entry »

Categories

Posted in:

Tuesday May 24th, 2016

Diagnosis through the retina can predict the evolution of patients with Multiple Sclerosis

A study led by IDIBAPS researchers has shown the usefulness of optical coherence tomography (OCT), a diagnostic imaging technique widely used in ophthalmology, for monitoring patients with multiple sclerosis (MS). The analysis of the retina with this technique can determine the risk of clinical worsening of those patients. Dr. Pablo Villoslada, head of the IDIBAPS Pathogenesis and new treatments in Multiple Sclerosis, and Dr. Elena H. Martinez-Lapiscina, researcher of the same group and head of the Visual Pathway Lab, coordinate this article published in The Lancet Neurology. Researchers from centers in Spain, Italy, France, Germany, Czech Republic, Holland, Canada and the United States have been involved in this study.

Read the rest of this entry »

No Comments
 Page 1 of 77  1  2  3  4  5 » ...  Last »